Comparisons · 2023-10-30
Semaglutide vs NAD+: research peptide comparison (UK)
Semaglutide 5 mg compared with NAD+ 1000 mg for UK laboratory supply: identity, documentation, storage, and how Solent lists both. Research use only.
Two defined materials
Semaglutide and NAD+ are separate catalogue entries. A lipidated GLP-1 receptor agonist peptide supplied strictly as a lyophilised laboratory reference compound — not a licensed medicine. A coenzyme studied in research into cellular-energy metabolism and sirtuin-pathway signalling in experimental models. Not a peptide. Neither is a licensed medicine. Solent does not recommend one over the other for any biological effect — choose by the protocol you have written.
Semaglutide
Semaglutide 5 mg is listed under metabolic. CAS 910463-68-2. Purity ≥ 99% (HPLC). Packed as lyophilised powder and dispatched from Southampton.
NAD+
NAD+ 1000 mg is listed under cellular senescence. CAS 53-84-9. Purity ≥ 99% (HPLC). Same standard: HPLC identity, lot number on the vial.
Buying both in the UK
UK laboratories can order Semaglutide and NAD+ on the same research invoice from the cheapest HPLC ≥99% Southampton catalogue we record. Next-working-day courier to most mainland postcodes. Confirm research-use-only at checkout.
Laboratory research only. Not for human or animal consumption. Research disclaimer.
Catalogue

A lipidated GLP-1 receptor agonist peptide supplied strictly as a lyophilised laboratory reference compound — not a licensed medicine.

A coenzyme studied in research into cellular-energy metabolism and sirtuin-pathway signalling in experimental models. Not a peptide.
More notes
- Sermorelin (GRF 1-29) vs Wolverine Stack: research peptide comparison (UK)
- Melanotan 2 vs Wolverine Stack: research peptide comparison (UK)
- Melanotan 2 vs Sermorelin (GRF 1-29): research peptide comparison (UK)
- PT-141 Bremelanotide vs Wolverine Stack: research peptide comparison (UK)
- PT-141 Bremelanotide vs Sermorelin (GRF 1-29): research peptide comparison (UK)
- PT-141 Bremelanotide vs Melanotan 2: research peptide comparison (UK)